Promasys^® Clinical Trial Platform provided to WHO/TDR  

Promasys has provided its Clinical Trial Workflow and Data Management system to TDR, the tropical disease research program based at the World Health Organization, to become the platform for its clinical trials.

In its battle to combat infectious diseases that  affect poor and marginalized populations, TDR facilitates, coordinates and funds clinical research  conducted in many countries where tropical diseases are endemic.

Professor Kesara Na-Bangchang, the coordinator of CDM-TDR Network said: “Promasys will ensure that we have more consistency between the different centres and will enforce quality standards. We are also very pleased with the contribution Promasys and their parent Centre for Human Drug Research will make to our programme to improve quality and standards.”

Promasys software will be used because of its user friendliness, its cost efficiency, and its robust quality system. Promasys software supports TDR in further implementing its own standards as well as international standards for clinical trials, in the centers that collaborate with TDR.

Prof Adam Cohen, CEO of Promasys’ parent organisation the Centre for Human Drug Research based in Leiden, the Netherlands said: “ We are very proud that such a respected organisation will be using Promasys worldwide for research on diseases that are the real threats to human existence. We look forward to working with the TDR programme based at WHO to share our knowledge and experience in clinical research”.

Under the license agreement between TDR and Promasys BV, Promasys  software will be installed in hospitals and clinical trial centers in China, India, Thailand, Cameroon as well as a number of other countries in Africa and South America. A special training program will be implemented by Promasys and its partner Kingslake to get the centers up and running quickly.